KP-1 - NOT A SPECIFIC MARKER - STAINING OF 137 SARCOMAS, 48 LYMPHOMAS, 28 CARCINOMAS, 7 MALIGNANT MELANOMAS AND 8 CYSTOSARCOMA-PHYLLODES

被引:30
作者
CASSIDY, M
LOFTUS, B
WHELAN, A
SABT, B
HICKEY, D
HENRY, K
LEADER, M
机构
[1] BEAUMONT HOSP,DUBLIN 9,IRELAND
[2] CHARING CROSS & WESTMINSTER MED SCH,LONDON SW1P 2AR,ENGLAND
来源
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 1994年 / 424卷 / 06期
关键词
KP-1; CD; 68; SOFT TISSUE SARCOMA; HISTIOCYTIC MARKER;
D O I
10.1007/BF01069744
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This study documents the reactions of the monoclonal antibody KP-1, which detects histiocytes in paraffin sections, with 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. The soft tissue sarcomas had been previously immunophenotyped. Positive staining was obtained in all categories of sarcoma except clear-cell sarcomas. Most categories of sarcoma showed staining in less than 10% of tumour cells although a minority of leiomyosarcomas showed more extensive staining. Five of 7 malignant melanomas were also positive while all lymphomas and carcinomas were negative. We conclude that KP-1 positivity is not helpful in supporting the histiocytic origin of a tumour and is of limited value in the differential diagnosis of soft tissue sarcomas or their separation from other categories of malignancy.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 26 条
[1]   UNDIFFERENTIATED (EMBRYONAL) SARCOMA OF THE LIVER - A TUMOR OF UNCERTAIN HISTOGENESIS SHOWING DIVERGENT DIFFERENTIATION [J].
AOYAMA, C ;
HACHITANDA, Y ;
SATO, JK ;
SAID, JW ;
SHIMADA, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1991, 15 (07) :615-624
[2]   THE LEUKOCYTE PROTEIN-L1 (CALPROTECTIN) - USEFULNESS AS AN IMMUNOHISTOCHEMICAL MARKER ANTIGEN AND PUTATIVE BIOLOGICAL FUNCTION [J].
BRANDTZAEG, P ;
DALE, I ;
GABRIELSEN, TO .
HISTOPATHOLOGY, 1992, 21 (02) :191-196
[3]   KP1 (CD 68) STAINING OF MALIGNANT MELANOMAS [J].
FACCHETTI, F ;
BERTALOT, G ;
GRIGOLATO, PG .
HISTOPATHOLOGY, 1991, 19 (02) :141-145
[4]   LITTORAL CELL ANGIOMA - A NOVEL SPLENIC VASCULAR LESION DEMONSTRATING HISTIOCYTIC DIFFERENTIATION [J].
FALK, S ;
STUTTE, HJ ;
FRIZZERA, G .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1991, 15 (11) :1023-1033
[5]  
FLETCHER CDM, 1992, RECENT ADV HISTOPATH, V15, P113
[6]   USE OF MONOCLONAL-ANTIBODY KP1 FOR IDENTIFYING NORMAL AND NEOPLASTIC HUMAN MAST-CELLS [J].
HORNY, HP ;
SCHAUMBURGLEVER, G ;
BOLZ, S ;
GEERTS, ML ;
KAISERLING, E .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (09) :719-722
[7]   MALIGNANT FIBROUS HISTIOCYTOMA - PROLIFERATIVE COMPARTMENT AND HETEROGENEITY OF HISTIOCYTIC CELLS [J].
IWASAKI, H ;
YOSHITAKE, K ;
OHJIMI, Y ;
KIKUCHI, M ;
ISAYAMA, T ;
YOH, S ;
SHINOHARA, N ;
ENJOJI, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (08) :735-745
[8]  
LEADER M, 1987, HISTOPATHOLOGY, V11, P63
[9]   AN ANALYSIS OF THE SENSITIVITY AND SPECIFICITY OF THE CYTOKERATIN MARKER CAM 5.2 FOR EPITHELIAL TUMORS - RESULTS OF A STUDY OF 203 SARCOMAS, 50 CARCINOMAS AND 28 MALIGNANT MELANOMAS [J].
LEADER, M ;
PATEL, J ;
MAKIN, C ;
HENRY, K .
HISTOPATHOLOGY, 1986, 10 (12) :1315-1324
[10]   STAINING FOR FACTOR-VIII RELATED ANTIGEN AND ULEX-EUROPAEUS AGGLUTININ-I (UEA-I) IN 230 TUMORS - AN ASSESSMENT OF THEIR SPECIFICITY FOR ANGIOSARCOMA AND KAPOSIS-SARCOMA [J].
LEADER, M ;
COLLINS, M ;
PATEL, J ;
HENRY, K .
HISTOPATHOLOGY, 1986, 10 (11) :1153-1162